Thermo Fisher Scientific is a leading provider of RNAi products and services, including RNA synthesis chemistry, cell-based imaging and analysis, and RNAi technologies for drug discovery and therapeutic development. Their RNAi services can assist across target discovery, validation, mechanism of action studies, preclinical safety assessment, and clinical trials. Customers have access to Thermo Fisher's technologies and expertise in RNAi delivery optimization, high content screening, early toxicity profiling, and more through their RNAi contract services.